Archive WILEX Ad-hoc- and Press Releases 2007

ENGLISH DEUTSCH

Selected press releases of the former years can be found here.

18 December 2007
PR: WILEX updates the status of the RENCAREX®* Phase IIIARISER Study following the positive interim analysis for futility
13 December 2007
AH: WILEX announces positive result of the interim analysis for futility of its Phase III ARISER trial with RENCAREX®*

PR: WILEX announces positive result of the interim analysis for futility of its Phase III ARISER trial with RENCAREX®*
12 October 2007
AH: WILEX´ second product enters Phase III trial: IND approval from FDA for registration trial with CA9-SCAN

PR: WILEX´ second product enters Phase III trial: IND approval from FDA for registration trial with CA9-SCAN
11 October 2007
PR: WILEX Q3 report 2007: progress with development projects – 2007 financial outlook confirmed
01 October 2007
AH: Supervisory Board appoints Dr. Thomas Borcholte as Chief Business Officer and member of Executive Management Board of WILEX AG

PR: Supervisory Board appoints Thomas Borcholte as Chief Business Officer and member of the Executive Management Board of WILEX AG
24 September 2007
PR: Phase Ib trial with WX-671 in patients with head & neck cancer successfully completed
12 July 2007
AH: WILEX AG – improved financial outlook due to cost optimization

PR: WILEX HY1 2007: projects in line with expectations –improved financial outlook
03 July 2007
PR: SAVE THE DATE:
First international symposium on functional and clinical aspects of the tumour antigen CA-IX to be held on 14 November 2007 in Brussels

29 June 2007
PR: WILEX to follow FDA advice and apply for a special protocol assessment (SPA) for CA9-SCAN
26 June 2007
PR: Patient recruitment started in clinical Phase II trial with WX-671 in pancreatic cancer
13 June 2007
PR: Annual General Meeting appoints new Supervisory Board Members
13 April 2007
PR: WILEX publishes Q1 2007 figures – results in line with expectations
03 April 2007
PR: WILEX gives positive update of current pivotal Phase III trial of RENCAREX®*
27 February 2007
PR: WILEX reports a successfull financial year 2006 – positive outlook and guidance 2007
Seite gelesen: 431 | Heute: 4